Literature DB >> 30927966

Can we predict lesion detection rates in second-look ultrasound of MRI-detected breast lesions? A systematic analysis.

Alexander Bumberger1, Paola Clauser1, Michael Kolta1, Panagiotis Kapetas1, Maria Bernathova1, Thomas H Helbich1, Katja Pinker1, Pascal A Baltzer2.   

Abstract

PURPOSE: To predict detection rates (DR) in second-look ultrasound of MRI-detected breast lesions by systematically combining clinical and anthropomorphic features.
METHODS: A total of 104 suspicious breast-lesions, that were initially detected on breast MRI and underwent subsequent SLU from January 2013 through December 2013, were evaluated in this retrospective analysis. All images were reviewed by an experienced radiologist for this study. Both anthropomorphic, spatial and BI-RADS lesion features were recorded. Uni- and multivariate Classification and Regression Trees (CRT) statistics were used to predict SLU DR by these features.
RESULTS: Among 104 MRI-detected lesions, 58 (55.8%) showed a correlate on SLU. In univariate analysis, homogeneous fatty or dense fibro-glandular-tissue-composition (FGT) as assessed by ultrasound, segmental non-mass-distribution pattern and small breast size as assessed by MRI were significantly associated with higher DR on SLU. The remaining BI-RADS features did not significantly affect SLU DR according to our data. The predictive model could stratify the likelihood of SLU correlates as high, intermediate and low according to FGT, lesion type, size and position.
CONCLUSIONS: By systematically combining the features FGT, lesion type, size and position, we could predict SLU DR of MRI-detected breast lesions. This may help to decide the preferable method for lesion biopsy or follow-up in clinical practice.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Breast; Breast neoplasms; Clinical decision making; Magnetic resonance imaging; Mammary; Ultrasonography

Mesh:

Year:  2019        PMID: 30927966     DOI: 10.1016/j.ejrad.2019.02.008

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

1.  Dynamic contrast-enhanced breast magnetic resonance imaging findings that affect the magnetic resonance-directed ultrasound correlation of non-mass enhancement lesions: a single-center retrospective study.

Authors:  Almila Coskun Bilge; Pinar Ilhan Demir; Hale Aydin; Isil Esen Bostanci
Journal:  Br J Radiol       Date:  2022-01-07       Impact factor: 3.629

2.  Assessment of MRI-Detected Breast Lesions: A Benign Correlate on Second-Look Ultrasound Can Safely Exclude Malignancy.

Authors:  Karin Hellerhoff; Hanna Dietrich; Regina Schinner; Dorothea Rjosk-Dendorfer; Anikó Sztrókay-Gaul; Maximilian Reiser; Susanne Grandl
Journal:  Breast Care (Basel)       Date:  2021-01-18       Impact factor: 2.268

3.  Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging.

Authors:  Ulrich Bick; Rubina M Trimboli; Alexandra Athanasiou; Corinne Balleyguier; Pascal A T Baltzer; Maria Bernathova; Krisztina Borbély; Boris Brkljacic; Luca A Carbonaro; Paola Clauser; Enrico Cassano; Catherine Colin; Gul Esen; Andrew Evans; Eva M Fallenberg; Michael H Fuchsjaeger; Fiona J Gilbert; Thomas H Helbich; Sylvia H Heywang-Köbrunner; Michel Herranz; Karen Kinkel; Fleur Kilburn-Toppin; Christiane K Kuhl; Mihai Lesaru; Marc B I Lobbes; Ritse M Mann; Laura Martincich; Pietro Panizza; Federica Pediconi; Ruud M Pijnappel; Katja Pinker; Simone Schiaffino; Tamar Sella; Isabelle Thomassin-Naggara; Anne Tardivon; Chantal Van Ongeval; Matthew G Wallis; Sophia Zackrisson; Gabor Forrai; Julia Camps Herrero; Francesco Sardanelli
Journal:  Insights Imaging       Date:  2020-02-05

4.  Can second-look ultrasound downgrade MRI-detected lesions? A retrospective study.

Authors:  Michael Kolta; Paola Clauser; Panagiotis Kapetas; Maria Bernathova; Katja Pinker; Thomas H Helbich; Pascal A T Baltzer
Journal:  Eur J Radiol       Date:  2020-04-11       Impact factor: 3.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.